PT876398E - Inducao de respostas imunitarias contra determinantes desejados - Google Patents

Inducao de respostas imunitarias contra determinantes desejados

Info

Publication number
PT876398E
PT876398E PT97902074T PT97902074T PT876398E PT 876398 E PT876398 E PT 876398E PT 97902074 T PT97902074 T PT 97902074T PT 97902074 T PT97902074 T PT 97902074T PT 876398 E PT876398 E PT 876398E
Authority
PT
Portugal
Prior art keywords
responses against
induction
immune responses
against desired
determinants
Prior art date
Application number
PT97902074T
Other languages
English (en)
Inventor
Alessandro Sette
Shawn Defrees
Jeffery L Alexander
Original Assignee
Epimmune Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Epimmune Inc filed Critical Epimmune Inc
Publication of PT876398E publication Critical patent/PT876398E/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/08Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/385Haptens or antigens, bound to carriers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K9/00Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/57Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/60Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031Proteins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/60Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031Proteins
    • A61K2039/605MHC molecules or ligands thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Steroid Compounds (AREA)
  • Control Of High-Frequency Heating Circuits (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PT97902074T 1996-01-24 1997-01-23 Inducao de respostas imunitarias contra determinantes desejados PT876398E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US1051096P 1996-01-24 1996-01-24

Publications (1)

Publication Number Publication Date
PT876398E true PT876398E (pt) 2002-12-31

Family

ID=21746084

Family Applications (1)

Application Number Title Priority Date Filing Date
PT97902074T PT876398E (pt) 1996-01-24 1997-01-23 Inducao de respostas imunitarias contra determinantes desejados

Country Status (12)

Country Link
EP (1) EP0876398B1 (pt)
JP (1) JP4063879B2 (pt)
CN (1) CN1214051A (pt)
AT (1) ATE220687T1 (pt)
AU (1) AU1582797A (pt)
BR (1) BR9710404A (pt)
CA (1) CA2242878C (pt)
DE (1) DE69714011T2 (pt)
DK (1) DK0876398T3 (pt)
ES (1) ES2177927T3 (pt)
PT (1) PT876398E (pt)
WO (1) WO1997026784A1 (pt)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6528061B1 (en) * 1997-09-04 2003-03-04 Pasteur Institut Immunogenic polypeptides that mimic a surface polysaccharide antigen of a pathogenic microorganism, method for obtaining the same, and their use in vaccine compositions
EP1903056A3 (en) 2002-12-10 2008-05-07 Idm Pharma, Inc. HLA-A1, -A2 -A3, -A24, -B7, and -B44 binding peptides comprising tumor associated antigen epitopes, and compositions thereof
CA2505870A1 (en) * 2002-12-11 2004-06-24 Soren Mouritsen Targeting single epitopes
WO2004094454A2 (en) 2003-04-18 2004-11-04 Idm Pharma, Inc. Hla-a2 tumor associated antigen peptides and compositions
ES2310072B1 (es) 2005-12-23 2009-11-16 Proyecto De Biomedicina Cima, S.L. Nuevos peptidos determinantes antigenicos t colaboradores (/dth).
WO2009025777A1 (en) * 2007-08-17 2009-02-26 University Of Maryland Carbohydrate functionalized catanionic surfactant vesicles for drug delivery
WO2010086294A2 (en) 2009-01-28 2010-08-05 Epimmune Inc. Pan-dr binding polypeptides and uses thereof
WO2012123269A1 (en) 2011-03-11 2012-09-20 Proyecto De Biomedicina Cima, S.L. Immunogenic compositions and methods for their use
US10588952B2 (en) * 2013-03-29 2020-03-17 Sumitomo Dainippon Pharma Co., Ltd. Conjugate vaccine using trimming function of ERAP1
KR102121638B1 (ko) 2013-03-29 2020-06-10 다이닛본 스미토모 세이야꾸 가부시끼가이샤 Wt1 항원 펩티드 콘쥬게이트 백신
CA2919835A1 (en) 2013-07-31 2015-02-05 Board Of Trustees Of The University Of Arkansas Compositions for and methods of treating and preventing cancer targeting tumor associated carbohydrate antigens
CN106456766B (zh) * 2014-03-19 2020-03-10 台湾基督长老教会马偕医疗财团法人马偕纪念医院 抗免疫原性糖肽的抗体、包含其的组合物及其用途
CN107141355B (zh) * 2017-05-31 2021-05-14 中国人民解放军第四军医大学 一种htnv抗原表位线性串联多肽及表位肽-复合物四聚体和应用
CN109991422A (zh) * 2017-12-29 2019-07-09 复旦大学 基于特异抗血清的棕榈酰化修饰蛋白质的检测方法
US20230181721A1 (en) 2020-05-11 2023-06-15 Ose Immunotherapeutics Vaccine against sars-cov virus
KR102261457B1 (ko) * 2020-07-22 2021-06-09 (주)쓰리에이치바이오 면역 치료제용 펩타이드
US20230134067A1 (en) * 2020-07-22 2023-05-04 3H Bio. Co., Ltd. A peptide used for immunotherapeutics
WO2022268916A2 (en) 2021-06-23 2022-12-29 Ose Immunotherapeutics Pan-coronavirus peptide vaccine

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2157510A1 (en) * 1993-03-05 1994-09-15 Howard M. Grey Hla-a2.1 binding peptides and their uses
AU698962B2 (en) * 1993-09-14 1998-11-12 Epimmune, Inc. Alteration of immune response using pan DR-binding peptides

Also Published As

Publication number Publication date
ATE220687T1 (de) 2002-08-15
WO1997026784A1 (en) 1997-07-31
CA2242878C (en) 2010-06-22
JP2000504328A (ja) 2000-04-11
CA2242878A1 (en) 1997-07-31
CN1214051A (zh) 1999-04-14
DE69714011T2 (de) 2003-02-27
EP0876398B1 (en) 2002-07-17
DK0876398T3 (da) 2002-08-12
EP0876398A1 (en) 1998-11-11
DE69714011D1 (de) 2002-08-22
ES2177927T3 (es) 2002-12-16
JP4063879B2 (ja) 2008-03-19
BR9710404A (pt) 1999-08-17
AU1582797A (en) 1997-08-20

Similar Documents

Publication Publication Date Title
PT876398E (pt) Inducao de respostas imunitarias contra determinantes desejados
WO2004032829A3 (en) Immunostimulatory compositions and methods of stimulating an immune response
CY1112927T1 (el) Αντισωματα κατα της ανθρωπινης il-12
MY155218A (en) Small molecules useful in the treatment of inflammatory disease
PL336580A1 (en) Fine-molecular compounds useful in treating inflammatory diseases
MY125202A (en) Vaccine
DK0760848T3 (da) Lactobacillusstammer af menneskelig oprindelse, deres sammensætninger og anvendelse deraf
MXPA02001911A (es) Anticuerpos ctla-4 humanos y sus usos.
ATE314095T1 (de) Virusähnliche partikel zur induktion von autoantikörpern
ES2113980T3 (es) Ligandos solubles para cd40.
NO983999L (no) Peptidimmunogener for vaksinasjon mot og behandling av allergi
DK0827537T3 (da) Chromatin-regulator-gener
DE69839696D1 (de) Anellierte dihydropyrane
NO964238D0 (no) Halofantrin-fri-base for behandling av malaria og blandinger
DK1146906T3 (da) Mukosalt afgivelsessystem
DE69723580D1 (de) Impfstoff gegen metastasierenden kolorektalkrebs.
HK1024408A1 (en) Use of pramipexole in the treatment of restless legs syndrome
FR2715304B1 (fr) Vaccin anti-allergique.
NO20005548D0 (no) Mykobakterieinhibitorer
AP2010A (en) Immunogenic liposome compositions.
ATE353226T1 (de) Adjuvanszusammensetzung enthaltend fha oder ein fha-fragment in freier form
MD980129A (en) Antiherpetic remedy
EP1555316A3 (en) Antigen library immunization
ATE313329T1 (de) Disaccharidderivate zur behandlung von hyperglykämien
TR199800850T2 (xx) Kan� d�zenleyici bile�imler.